Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis
Authors:
- Rafael BañaresRBRafael Bañares
- Agustín AlbillosAAAgustín Albillos
- Diego RincónDRDiego Rincón
- Sonia AlonsoSASonia Alonso
- Mónica GonzálezMGMónica González
- MónicaMÓMónica
- Luis Ruiz‐Del‐ArbolLRLuis Ruiz‐Del‐Arbol
- Magdalena SalcedoMSMagdalena Salcedo
- Luis‐Miguel MolineroLMLuis‐Miguel Molinero
Top Cited Papers
- 1 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (3) , 609-615
Abstract
Endoscopic therapy, involving either injection sclerosis or band ligation, is considered the intervention of first choice for acute variceal bleeding (AVB). Pharmacologic agents have also been shown to be highly effective in the control of the bleeding episode. The purpose of this meta-analysis was to assess whether vasoactive drugs may improve the efficacy of endoscopic therapy (injection sclerosis or band ligation) in the control of AVB and thus increase survival rates. Computer databases and scientific meeting abstracts from 1994 to 2001 were used to search for randomized trials that compared the combined use of endoscopic and drug therapy with endoscopic therapy alone in the control of AVB. Eight trials involving 939 patients fulfilled the selection criteria and the following evaluated by standard meta-analysis methods: initial hemostasis, 5-day hemostasis, 5-day mortality, and adverse events. Combined treatment improved initial control of bleeding (relative risk [RR], 1.12; 95% confidence interval (CI), 1.02-1.23), and 5-day hemostasis (RR, 1.28; 95% CI, 1.18-1.39), with numbers of patients needed to treat (NNT) of 8 and 5, respectively. The difference in favor of combined treatment remained significant when trials that used drugs other than octreotide or that included a low proportion of alcoholic patients (<40%) or high-risk cirrhotic patients (<35%) were excluded. Mortality was not significantly decreased by combined therapy (RR, 0.73; 95% CI, 0.45-1.18). Severe adverse events were similar in both groups. In conclusion, in patients with AVB, pharmacologic agents improve the efficacy of endoscopic therapy to achieve initial control of bleeding and 5-day hemostasis, yet fail to affect mortality.Keywords
This publication has 21 references indexed in Scilit:
- Octreotide for acute esophageal variceal bleeding: A meta-analysisGastroenterology, 2001
- Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertensionGastroenterology, 2001
- Multicenter Randomized Controlled Trial of Terlipressin Versus Sclerotherapy in the Treatment of Acute Variceal Bleeding: The TEST StudyHepatology, 2000
- Portal hypertension and variceal bleeding: An AASLD single topic symposium†Hepatology, 1998
- Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosisGastrointestinal Endoscopy, 1997
- Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligationThe Lancet, 1995
- The treatment of portal hypertension: A meta-analytic reviewHepatology, 1995
- A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleedingHepatology, 1994
- Endoscopic Ligation Compared with Sclerotherapy for the Treatment of Bleeding Esophageal VaricesAnnals of Internal Medicine, 1993
- Definitions, methodology and therapeutic strategies in portal hypertensionJournal of Hepatology, 1992